UroGen Pharma, Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$7.3M
Doctors Paid
7,252
Transactions
25,229
2024 Total
$1.7M
Payment Breakdown by Category
Research$1.7M (22.9%)
Food & Beverage$763,178 (10.4%)
Consulting$649,663 (8.9%)
Travel$157,085 (2.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3.0M | 76 | 41.4% |
| Unspecified | $1.7M | 778 | 22.9% |
| Honoraria | $980,904 | 293 | 13.4% |
| Food and Beverage | $763,178 | 23,056 | 10.4% |
| Consulting Fee | $649,663 | 235 | 8.9% |
| Travel and Lodging | $157,085 | 365 | 2.1% |
| Space rental or facility fees (teaching hospital only) | $34,400 | 11 | 0.5% |
| Gift | $30,250 | 74 | 0.4% |
| Education | $4,327 | 341 | 0.1% |
Payments by Type
General
$5.7M
24,451 transactions
Research
$1.7M
778 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| UROGEN BL-006 | $472,488 | 0 | 188 |
| UROGEN PHARMA BL007 | $156,290 | 0 | 91 |
| UTRACT JELMYTO REGISTRY - A REGISTRY OF PATIENTS WITH UPPER TRACT UROTHELIAL CANCER (UTUC) TREATED WITH JELMYTO (UTRACT) | $104,235 | 3 | 19 |
| UTRACT JELMYTO REGISTRY A REGISTRY OF PATIENTS WITH UPPER TRACT UROTHELIAL CANCER UTUC TREATED WITH JELMYTO UTRACT | $96,448 | 0 | 7 |
| QUALITY OF CARE AND COST-ANALYSIS IN PATIENTS WITH UPPER TRACT UROTHELIAL CARCINOMA | $89,568 | 0 | 2 |
| UROGEN BL006 | $56,875 | 0 | 320 |
| BL007 - A ROLLOVER STUDY TO FOLLOW THE LONG-TERM OUTCOMES OF PATIENTS FROM STUDY UT001 (FORMERLY TC-UT-03) AND STUDY TC-BC-12 | $33,087 | 0 | 56 |
| OLYMPUS | $19,214 | 0 | 36 |
| UROGEN BL010 | $13,079 | 0 | 22 |
| OLYMPUS FINAL MANUSCRIPT | $9,152 | 26 | 26 |
| BL010 | $1,306 | 0 | 3 |
Payments by Medical Specialty
Top Paid Doctors — Page 4
| Doctor | Specialty | Location | Total | 2024 |
|---|---|---|---|---|
| Edward Messing, Md, MD | Urology | Rochester, NY | $4,203 | $0 |
| Dr. Eric Singer, Md, Ma, MD, MA | Urology | Columbus, OH | $4,187 | $0 |
| Dr. Jeffrey Holzbeierlein, Md, MD | Urology | Kansas City, KS | $4,187 | $0 |
| Dr. Daniel Saltzstein, Md, MD | Surgery | San Antonio, TX | $4,132 | $0 |
| Dr. Bogdana Schmidt, Md, MD | Urology | Stanford, CA | $4,087 | $0 |
| Richard Medley, Md, MD | Urology | New Albany, IN | $4,068 | $0 |
| Hristos Kaimakliotis, Md, MD | Urology | Indianapolis, IN | $4,001 | $0 |
| Ralph Henderson, M.d, M.D | Urology | Shreveport, LA | $3,940 | $0 |
| Craig Labbate, Md, MD | Urology | Highland Park, IL | $3,875 | $0 |
| Dr. Lambros Stamatakis, M.d, M.D | Urology | Washington, DC | $3,737 | $0 |
| Ahmad Shabsigh, M.d, M.D | Urology | Columbus, OH | $3,729 | $0 |
| Dr. Mark Saslawsky, M.d, M.D | Urology | Memphis, TN | $3,702 | $0 |
| Dr. Geoffrey Sklar, M.d, M.D | Urology | Baltimore, MD | $3,610 | $0 |
| Dr. Fady Ghali, M.d, M.D | Urology | New Haven, CT | $3,580 | $0 |
| Dr. Timothy Lyon, M.d, M.D | Urology | Jacksonville, FL | $3,474 | $0 |
| Dr. Matthew Mossanen, M.d, M.D | Student in an Organized Health Care Education/Training Program | Boston, MA | $3,342 | $0 |
| Christopher Pieczonka, M.d, M.D | Urology | Syracuse, NY | $3,285 | $0 |
| Gordon Brown, Do, DO | Urology | Cherry Hill, NJ | $3,243 | $0 |
| Marcus Quek, Md, MD | Urology | Maywood, IL | $3,228 | $0 |
| Kyle Rose | Urology | New Orleans, LA | $2,983 | $0 |
| Ruchika Talwar | Urology | Nashville, TN | $2,950 | $0 |
| Dr. David Morris, Md, MD | Student in an Organized Health Care Education/Training Program | Hendersonville, TN | $2,823 | $0 |
| Brooke Edwards, M.d, M.D | Student in an Organized Health Care Education/Training Program | Crestview Hills, KY | $2,764 | $0 |
| Dr. Surena Matin, M.d., F.a.c.s, M.D., F.A.C.S | Urology | Houston, TX | $2,752 | $0 |
| David Cahn, Md, MD | Urology | Golden, CO | $2,744 | $0 |
About UroGen Pharma, Inc.
UroGen Pharma, Inc. has made $7.3M in payments to 7,252 healthcare providers, recorded across 25,229 transactions in the CMS Open Payments database. In 2024, the company paid $1.7M. The top product by payment volume is JELMYTO ($2.3M).
Payments were distributed across 99 medical specialties. The top specialty by payment amount is Urology ($4.0M to 4,184 doctors).
Payment categories include: Food & Beverage ($763,178), Consulting ($649,663), Research ($1.7M), Travel & Lodging ($157,085).
UroGen Pharma, Inc. is associated with 1 products in the CMS Open Payments database.